Outset Medical, Inc.
OM
$19.96
-$0.32-1.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.56% | 25.94% | 19.76% | 6.50% | 0.74% |
| Total Depreciation and Amortization | -5.50% | -1.41% | 2.40% | 6.60% | 11.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.27% | -13.07% | -6.26% | 6.05% | 1.70% |
| Change in Net Operating Assets | -317.54% | -3,223.16% | -181.40% | -73.77% | 75.86% |
| Cash from Operations | 27.52% | 11.47% | 12.15% | 2.87% | 12.90% |
| Capital Expenditure | 77.18% | 73.49% | 57.25% | 64.23% | 61.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 251.62% | 21.26% | 71.12% | 660.38% | 207.66% |
| Cash from Investing | 297.57% | 25.19% | 144.62% | 1,948.30% | 170.56% |
| Total Debt Issued | -1.48% | 100.22% | 3.84% | 3.84% | 3.84% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.63% | -78.10% | -79.26% | -34.67% | -24.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -48.67% | 55.48% | 34.22% | 42.40% | 43.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,143.70% | 1,282.22% | 94.77% | 102.13% | 96.12% |